Mitchell H. Finer's Net Worth
$26.6 Million
Who is Mitchell H. Finer?
Mitchell H. Finer has an estimated net worth of $26.6 Million. This is based on reported shares across multiple companies, which include bluebird bio, Inc., Adverum Biotechnologies, Inc., TCR2 THERAPEUTICS INC., TURMERIC ACQUISITION CORP., and Oncorus, Inc..
SEC CIK
Mitchell H. Finer's CIK is 0001578432
Past Insider Trading and Trends
2015 was Mitchell H. Finer's most active year for acquiring shares with 12 total transactions. Mitchell H. Finer's most active month to acquire stocks was the month of April. 2015 was Mitchell H. Finer's most active year for disposing of shares, totalling 65 transactions. Mitchell H. Finer's most active month to dispose stocks was the month of March. 2015 saw Mitchell H. Finer paying a total of $846,441.26 for 150,000 shares, this is the most they've acquired in one year. In 2015 Mitchell H. Finer cashed out on 300,000 shares for a total of $19,611,069.91, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
bluebird bio, Inc. (BLUE) Snapshot price: $0.53
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$107.36 | -$2,486,750.35 |
0
|
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
$87.91 | -$2,472,296.34 |
0
|
Scheduled
|
May 22
| ||
Form 4
|
—
|
0
|
$79.92 | -$2,232,511.79 |
0
|
Scheduled
|
May 15
| ||
Form 4
|
—
|
0
|
$68.58 | -$1,897,826.29 |
0
|
Scheduled
|
May 4
| ||
Form 4
|
—
|
0
|
$65.64 | -$1,811,884.85 |
0
|
Scheduled
|
Apr 20
| ||
Form 4
|
—
|
0
|
$61.14 | -$1,727,446.16 |
0
|
Scheduled
|
Apr 6
| ||
Form 4
|
—
|
0
|
$60.02 | -$3,475,791.85 |
0
|
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
$45.68 | -$2,660,121.01 |
0
|
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
$20.33 | -$697,524.83 |
0
|
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$17.81 | -$1,084,793.92 |
0
|
Oct 8
| |||
Form 4
|
—
|
0
|
$19.48 | -$666,900.00 |
0
|
Scheduled
|
Sep 2
| ||
Form 4
|
—
|
0
|
$20.40 | -$388,900.00 |
0
|
Scheduled
|
Jun 16
| ||
Form 4
|
—
|
0
|
$11.58 | -$170,080.00 |
0
|
Scheduled
|
Jun 2
| ||
Form 4
|
—
|
0
|
$12.87 | -$190,720.00 |
0
|
Scheduled
|
Mar 3
| ||
Form 4
|
—
|
0
|
$12.24 | -$225,700.00 |
0
|
Scheduled
|
Jan 16
| ||
Form 4
|
—
|
0
|
$10.80 | -$354,600.00 |
0
|
Scheduled
|
Dec 16
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adverum Biotechnologies, Inc. (ADVM) Snapshot price: $6.76
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
| +3.92% | 22.73K |
—
|
—
| 603.07K |
Jun 12
| |||
Form 4
| +4.34% | 24.16K |
—
|
—
| 580.34K |
May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TCR2 THERAPEUTICS INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TURMERIC ACQUISITION CORP. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oncorus, Inc. (ONCR) Snapshot price: $0.024
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||